Enzyme immunoassay for the specific and quantitative determination of free Golimumab (Simponi®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Golimumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Simponi® is a trademark of Janssen Biotech, Inc./Merck & Co.